BIOLOGICAL · Unmapped registry intervention
PGx testing guided treatment (PGT)
Find medicine records ·
Find other trials using this name
Clinical trial
Prospective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis
NCT02566057
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedProspective Pharmacogenetic Testing and Clinical Outcomes in Patients With Early-Phase Psychosis
Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Schizophreniaverified · MONDO: schizophrenia
Psychotic Disordersunresolved
Bipolar Disorderverified · MONDO: bipolar disorder
Interventions
PGx testing guided treatment (PGT)BIOLOGICAL
Sponsors & collaborators
Northwell Healthlead sponsor
Genomind, LLCcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02566057 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.